Showing 251-260 of 2002 results for "".
“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approaches-to-ak-management/20133/When confronted with AK, dermatologists are armed with various treatment options, including destructive and field-directed therapies. Vishal Patel, MD and Neal Bhatia, MD talk about their approach to decision-making.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Atopic Dermatitis Guidelines Update
https://practicaldermatology.com/topics/general-topics/atopic-dermatitis-guidelines-update/18949/Peter Lio, MD speaks with Joel Cohen, MD about atopic dermatitis consensus recommendations, particularly the differences among different medical specialties. He also discusses how global guidelines may begin to take shape.Ask an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Skin Cancer Prevention: Can Laser Therapy Help?
https://practicaldermatology.com/conferences/scale-2023/skin-cancer-prevention-can-laser-therapy-help/20205/Non-ablative fractional laser treatments may dramatically the reduce risk of skin cancer recurrence. Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss the science behind this intriguing finding.First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.Insights on Care for Skin of Color, Part 2
https://practicaldermatology.com/topics/skin-of-color/insights-on-care-for-skin-of-color-part-2/18185/Hilary Baldwin, MD and James Q. Del Rosso, DO continue their discussion with host Neal Bhatia, MD about managing skin of color. They address long-term management strategies and the need for cultural awareness.Noah Worcester 2024: Dr. Jogi on Hair Loss
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-jogi-hair-loss/24590/Joel L. Cohen, MD, FAAD, interviews Reena Jogi, MD about her lecture on hair loss and platelet-rich plasma at the 2024 Noah Worcester Dermatological Society meeting.Insights on Care for Skin of Color, Part 1
https://practicaldermatology.com/topics/skin-of-color/insights-on-care-for-skin-of-color-part-1/18184/The full spectrum of skin phototypes means that there is no "typical presentation" of skin disease. Host Neal Bhatia, MD speaks with James Q. Del Rosso, DO and Hilary Baldwin, MD about patients' needs during isolation and beyond.